- Health & Pharmaceuticals›
- Physicians, Hospitals & Pharmacies›
Medicare inpatient hospital ALOS in U.S. cases by disease and IDN status 2016
Medicare inpatient hospital ALOS in U.S. cases by disease and IDN status 2016
Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*
This statistic shows the average length of Medicare primary inpatient hospital stays in the United States in 2016, by disease. In this year, an primary Medicare asthma patient stayed an average of 3.8 days in IDN hospitals. Medicare currently provides coverage for the largest portion of inpatient cases. Among the selected medical conditions, diabetes mellitus patients had the highest average length of stay, with almost five days.
Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*
Loading statistic...
| IDN-hospitals | Non-IDN-hospitals | |
|---|---|---|
| Angina | 3.3 | 2.7 |
| Asthma | 3.8 | 3.6 |
| Diabetes mellitus | 4.7 | 4.1 |
| Hypertension | 2.7 | 2.8 |
| Prostate cancer | 3.5 | 4.1 |
| Rheumatoid arthritis | 3.3 | 3.7 |
| Stroke | 3.7 | 3.6 |
| IDN-hospitals | Non-IDN-hospitals | |
|---|---|---|
| Angina | 3.3 | 2.7 |
| Asthma | 3.8 | 3.6 |
| Diabetes mellitus | 4.7 | 4.1 |
| Hypertension | 2.7 | 2.8 |
| Prostate cancer | 3.5 | 4.1 |
| Rheumatoid arthritis | 3.3 | 3.7 |
| Stroke | 3.7 | 3.6 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the average length of Medicare primary inpatient hospital stays in the United States in 2016, by disease. In this year, an primary Medicare asthma patient stayed an average of 3.8 days in IDN hospitals. Medicare currently provides coverage for the largest portion of inpatient cases. Among the selected medical conditions, diabetes mellitus patients had the highest average length of stay, with almost five days.
Show more- Show sources information
- Show publisher information
- Release date
- September 2018
- Region
- United States
- Survey time period
- 2016
- Special properties
- only Medicare primary inpatient cases
- Supplementary notes
-
* IDN = integrated delivery network.
ALOS = average length of stay.
Source
- Show sources information
- Show publisher information
- Release date
- September 2018
More information
- Region
- United States
- Survey time period
- 2016
- Special properties
- only Medicare primary inpatient cases
- Supplementary notes
-
* IDN = integrated delivery network.
ALOS = average length of stay.
Other statistics on the topic
Prostate cancer in the U.S.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Prostate cancer in the U.S.
- 75 page/s
- English
- pptx
- Detailed references
Everything On "Prostate cancer in the U.S." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Prostate cancer in the U.S."
- Overview
The most important statistics
- Percentage of men in the U.S. with prostate cancer who were diagnosed at select stages as of 2018Stage at diagnosis among U.S. men with prostate cancer as of 2018
- Percentage of men in the U.S. with prostate cancer who stated prostate cancer had select impacts on their quality of life as of 2018Impacts of prostate cancer on life quality among U.S. men as of 2018
- Percentage of men in the U.S. with prostate cancer who stated select symptoms affected their daily life as of 2018Symptoms of prostate cancer that affected the daily lives of U.S. men as of 2018
- Incidence
The most important statistics
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)United States: incidence rates for cancer 2011-2015, by gender
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among men in 2009 and 2019
- Incidence rate of prostate cancer in the U.S. from 2011 to 2015, by ethnicity (per 100,000 population)Rate of prostate cancer among U.S. males 2011-2015, by ethnicity
- Number of new prostate cancer cases in the U.S. in 2015, by state (per 100,000 population)Prostate cancer incidence rate in the U.S. in 2015, by state
- Probability of developing prostate cancer in the U.S. from 2013 to 2015, by age Chance of developing prostate cancer in the U.S. 2013-2015, by age
- Survival rates
The most important statistics
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancerCancer: 5-year survival rates in the U.S. 2008-2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014Five-year survival rates for prostate and testicular cancer U.S. 1975-2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 2008 to 2014, by stage at diagnosisFive-year survival rates for prostate and testicular cancer U.S. 2008-2014, by stage
- Deaths
The most important statistics
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by diseasePercentage changes in selected causes of death in the U.S. 2000-2017
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)U.S. death rates from cancer by type and gender 2012-2016
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among men 2009 and 2019
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by prostate cancer in the U.S. 1950-2016
- Number of deaths due to prostate cancer in the United States from 1999 to 2015Number of deaths due to prostate cancer in U.S. 1999-2015
- Death rate for prostate cancer in the U.S. from 2012 to 2016, by ethnicity (per 100,000 population)Prostate cancer death rate in the U.S. 2012-2016, by ethnicity
- Number of prostate cancer deaths in the U.S. in 2015, by state (per 100,000 population)Prostate cancer death rate in the U.S. in 2015, by state
- Screening
The most important statistics
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ageProstate cancer test among men aged 50 years and older in the U.S. 2015, by age
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ethnicityProstate cancer test among men aged 50 years and older in the U.S. 2015, by ethnicity
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by educationProstate cancer test among men aged 50 years and older in the U.S. 2015, by education
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by regionProstate cancer test among men aged 50 years and older in the U.S. 2015, by region
- Treatment
The most important statistics
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012Distribution of treatment types for prostate cancer 2010-2012
- Medicines in development for cancer in the United States as of 2018, by all types*Medicines in development for cancer in the United States 2018
- Out-of-pocket costs per Medicare Part D retail prescription by therapy area in 2018 (in U.S. dollars)*Out of pocket costs of Medicare Part D retail prescription by drug therapy 2018
- Hospital care
The most important statistics
- Number of inpatient and outpatient cases per U.S. hospital by selected disease in 2016*Average inpatient and outpatient cases per hospital in the U.S. by disease 2016
- Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*Medicare inpatient hospital ALOS in U.S. cases by disease and IDN status 2016
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)Inpatient average length of stay in U.S. hospitals by cancer type 2008-2016
- Distribution of inpatient cases per hospital in the United States in 2016, by payer type and disease*Inpatient case share per U.S. hospital by insurance type and disease 2016
- Percent of inpatient charges reimbursed by Medicare by select condition in 2016*Medicare reimbursements of inpatient charges in the U.S. by condition 2016
- Average charge per inpatient case in U.S. acute-care hospitals by condition in 2016 (in U.S. dollars)*Charges for inpatients in U.S. hospitals per case by condition 2016
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Comparison of Medicare inpatient charges per stay relative to national mean U.S. 2013
- Medicare hospital inpatient charges by disease in the U.S. 2016
- Medicare hospital inpatient case charges by severity in the U.S. 2014
- Enrollment of Medicare Advantage by plan type 2011-2017
- Percentage of Medicare Advantage plans by plan type 2018
- Rate of adverse drug event in U.S. hospitals 2014, by origin and expected payer
- Adverse drug event characteristics in U.S. hospital stays 2014
- Ratio of private insured inpatient charges per stay relative to US mean 2013
- U.S. Medicare recipient 30-day readmission rates in 2014, by diagnosis
- Rate of adult inpatient stays involving atrial fibrillation U.S. 2014, by region
- Older patients characteristics in Medicare hospital inpatient stay by plan 2013
- Number of adult inpatient stays involving atrial fibrillation in U.S. 2014, by age
- Number of adult inpatient stays involving atrial fibrillation in U.S. 2014, by gender
- Rate of adult inpatient stays involving atrial fibrillation in U.S. 2014, by gender
- Rate of adult inpatient stays involving atrial fibrillation U.S. 2014, by ethnicity
- Number of adult inpatient stays involving atrial fibrillation U.S. 2014, by region
- Hospital inpatient discharges per 100 inhabitants in Slovakia 2003-2011
- Peru: individuals hospitalized 2010-2016, by gender
- Hospital inpatient discharges per 100 inhabitants in Romania 2007-2013
- Hospital inpatient discharges per 100 inhabitants in the Czech Republic 2003-2013
Studies
- Asthma Hospitalizations Among Children and Youth in Canada (2018)
- 2014 Physician Appointment Wait Times and Medicaid and Medicare Acceptance Rates
- Emergency Department Visits and Inpatient Stays Related to Back Problems, 2008
- Most Expensive Hospitalizations, 2008
- Hospital Admitted Patient Care and Adult Critical Care Activity 2017-18
- HealthGrades 2012 America's Best Hospitals Report
- Public Hospitals in the United States, 2008
- Medicaid Hospitalizations, 2008
- Components of Growth in Inpatient Hospital Costs, 1997–2009
- Statistics on Hospital-based Care in the United States 2009
- The National Hospital Bill: The Most Expensive Conditions by Payer, 2008
- Statistics on Hospital-based Care in the United States 2008
- Wait Time for Treatment in Hospital Emergency Departments: 2009
- Statistics on Hospital-based Care in the United States 2007
- Emergency department activity and waiting times data, Scotland
Statistics on "Prostate cancer in the U.S."
- Percentage of men in the U.S. with prostate cancer who were diagnosed at select stages as of 2018
- Percentage of men in the U.S. with prostate cancer who stated prostate cancer had select impacts on their quality of life as of 2018
- Percentage of men in the U.S. with prostate cancer who stated select symptoms affected their daily life as of 2018
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*
- Incidence rate of prostate cancer in the U.S. from 2011 to 2015, by ethnicity (per 100,000 population)
- Number of new prostate cancer cases in the U.S. in 2015, by state (per 100,000 population)
- Probability of developing prostate cancer in the U.S. from 2013 to 2015, by age
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancer
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 2008 to 2014, by stage at diagnosis
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by disease
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer type
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)
- Number of deaths due to prostate cancer in the United States from 1999 to 2015
- Death rate for prostate cancer in the U.S. from 2012 to 2016, by ethnicity (per 100,000 population)
- Number of prostate cancer deaths in the U.S. in 2015, by state (per 100,000 population)
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by age
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ethnicity
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by education
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by region
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012
- Medicines in development for cancer in the United States as of 2018, by all types*
- Out-of-pocket costs per Medicare Part D retail prescription by therapy area in 2018 (in U.S. dollars)*
- Number of inpatient and outpatient cases per U.S. hospital by selected disease in 2016*
- Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)
- Distribution of inpatient cases per hospital in the United States in 2016, by payer type and disease*
- Percent of inpatient charges reimbursed by Medicare by select condition in 2016*
- Average charge per inpatient case in U.S. acute-care hospitals by condition in 2016 (in U.S. dollars)*
- Ratio of mean inpatient charges per Medicare hospital stay relative to national Medicare mean by U.S. census division in 2013*
- Medicare hospital inpatient charges by select condition in 2016 (in U.S. dollars)*
- Medicare hospital inpatient charges per selected case by severity in 2014 (in U.S. dollars)*
- Medicare Advantage enrollment by plan type from 2011 to 2017*
- Distribution of available Medicare Advantage plans by plan type as of 2018*
- Rate of adverse drug events (ADEs) in U.S. hospitals in 2014, by origin and expected payer (per 10,000 stays)
- Inpatient hospital stays with adverse drug events (ADEs) by characteristic in the U.S. in 2014
- Ratio of mean inpatient charges per private insured hospital stay relative to national private insurance mean by U.S. census division in 2013*
- Top principle diagnoses with the highest 30-day readmission rates for Medicare inpatient hospitals stays in 2014 (per 100 index inpatient stays)
- Rate of inpatient stays involving atrial fibrillation among U.S. adults in 2014, by hospital region*
- Medicare Advantage versus fee-for-service plan inpatient hospital stays for older people in 2013, by patient characteristics
- Number of inpatient stays involving atrial fibrillation among U.S. adults in 2014, by age group
- Number of inpatient stays involving atrial fibrillation among U.S. adults in 2014, by gender
- Rate of inpatient stays involving atrial fibrillation among U.S. adults in 2014, by gender (per 100,000 population)
- Rate of inpatient stays involving atrial fibrillation among U.S. adults in 2014, by ethnicity (per 100,000 population)
- Number of inpatient stays involving atrial fibrillation among U.S. adults in 2014, by hospital region*
- Number of hospital inpatient discharges per 100 inhabitants in Slovakia from 2003 to 2011
- Number of individuals hospitalized in Peru from 2010 to 2016, by gender (in 1,000s)
- Number of hospital inpatient discharges per 100 inhabitants in Romania from 2007 to 2013
- Number of hospital inpatient discharges per 100 inhabitants in the Czech Republic from 2003 to 2013
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.